| Mifepristone | | |
| Major use for this drug:
treating endometriosis | | |
| Selective nonsteroidal
aromatase inhibitor; approved for use in treating breast tumors | | |
| Used for treating ovulation disorders in patients wishing to become pregnant | | |
| Competitive partial agonist inhibitor of estradiol; used as an adjunct in treating breast cancer (especially estrogen-positive tumors) | | |
| Beneficial effect of oral contraceptive use: | | |
| Most important human progestin | | |
| Brain neurotransmitter | | |
| Most common adverse effect in patients treated with clomiphene: | | |
| Hormonal contraception by progestin implants (subcutaneous) | | |
